TY  - JOUR 
AU  - Peters, T.M.A.
AU  - Merx, J.
AU  - Kooijman, P.C.
AU  - Noga, M.
AU  - de Boer, S.
AU  - van Gemert, L.A.
AU  - Salden, G.
AU  - Engelke, U.F.H.
AU  - Lefeber, D.J.
AU  - van Outersterp, R.E.
AU  - Berden, G.
AU  - Boltje, T.J.
AU  - Artuch, R.
AU  - Pías Peleteiro, Leticia Diana
AU  - García-Cazorla, Á.
AU  - Bari?, I.
AU  - Thöny, B.
AU  - Oomens, J.
AU  - Martens, J.
AU  - Wevers, R.A.
AU  - Verbeek, M.M.
AU  - Coene, K.L.M.
AU  - Willemsen, M.A.A.P.
PY  - 2023
SN  - 1573-2665
UR  - http://hdl.handle.net/20.500.11940/21788
AB  - We used next-generation metabolic screening to identify new biomarkers for improved diagnosis and pathophysiological understanding of glucose transporter type 1 deficiency syndrome (GLUT1DS), comparing metabolic cerebrospinal fluid (CSF) profiles from...
LA  - eng
KW  - Humans
KW  - Xylose
KW  - Glucose
KW  - Biomarkers
KW  - Brain
TI  - Novel cerebrospinal fluid biomarkers of glucose transporter type 1 deficiency syndrome: Implications beyond the brain's energy deficit
DO  - 10.1002/jimd.12554
T2  - Journal of Inherited Metabolic Disease
M2  - 66
KW  - AS Santiago
KW  - IDIS
VL  - 46
ER  -